Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AlloCure begins phase II study in acute kidney injury

Sep. 5, 2012

Adenosine-based therapy shows promise for the treatment of priapism

Sep. 4, 2012

Phase I/II data suggest transrectal administration of PRX-302 is well tolerated in BPH

Sep. 3, 2012

New data presented on Xiaflex in Peyronie's disease

Aug. 30, 2012

Chugai presents new highly potent and selective AXL inhibitor

Aug. 27, 2012

Folate-rapamycin conjugate shows promise to treat PKD

Aug. 23, 2012

New TRPM8 channel antagonists disclosed by Dompe Farmaceutici

Aug. 23, 2012

Collaboration yields novel prostanoid EP1 receptor antagonists

Aug. 21, 2012

New sildenafil formulation launched in Korea to treat erectile dysfunction

Aug. 21, 2012

Roche reports novel bradykinin B1 receptor antagonists

Aug. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...